After trading substantially lower during the middle of the day, stocks recovered in late trading to close within spitting distance of the unchanged milestone. The Centient Biotech 200™ lost 6.8 points (.2%) to close at 3363.06. We revisit one of our favorite stocks, Medarex, which inked yet another deal today (how many viable compounds do they have?), and some of the big movers, both up and down, on the day.
